These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1029 related items for PubMed ID: 26886314

  • 1. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S, Cathcart H, O'Reilly NJ.
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F, Huang J, Hussain MA.
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S, Cathcart H, O'Reilly NJ.
    Mol Pharm; 2018 Sep 04; 15(9):3796-3812. PubMed ID: 30020788
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P, Puri V, Bansal AK.
    Drug Dev Ind Pharm; 2014 Jan 04; 40(1):92-101. PubMed ID: 23301771
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y, Jones DS, Andrews GP.
    Mol Pharm; 2015 Apr 06; 12(4):1180-92. PubMed ID: 25692314
    [Abstract] [Full Text] [Related]

  • 10. Comparative Assessment of Miniaturized Screening Approaches for Selection of Polymers for Amorphous Drug Stabilization.
    Banda A, Manchanda A, Zhang W, Alba GM, Nagapudi K.
    J Pharm Sci; 2018 Mar 06; 107(3):897-908. PubMed ID: 29155235
    [Abstract] [Full Text] [Related]

  • 11. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
    Fridgeirsdottir GA, Harris RJ, Dryden IL, Fischer PM, Roberts CJ.
    Mol Pharm; 2018 May 07; 15(5):1826-1841. PubMed ID: 29533634
    [Abstract] [Full Text] [Related]

  • 12. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D, Chauhan H, Atef E.
    J Pharm Sci; 2014 Nov 07; 103(11):3511-3523. PubMed ID: 25196860
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
    Yang Z, Nollenberger K, Albers J, Qi S.
    Mol Pharm; 2014 Jul 07; 11(7):2453-65. PubMed ID: 24897345
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improving the Dissolution of Triclabendazole from Stable Crystalline Solid Dispersions Formulated for Oral Delivery.
    Real D, Orzan L, Leonardi D, Salomon CJ.
    AAPS PharmSciTech; 2019 Dec 05; 21(1):16. PubMed ID: 31807963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.